- Home
- VLT vs INCR Comparison
VLT vs INCR Comparison
Compare VLT & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLT
- INCR
- Stock Information
- Founded
- VLT 1989
- INCR 1994
- Country
- VLT United States
- INCR Israel
- Employees
- VLT N/A
- INCR N/A
- Industry
- VLT Trusts Except Educational Religious and Charitable
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- VLT Finance
- INCR Health Care
- Exchange
- VLT Nasdaq
- INCR Nasdaq
- Market Cap
- VLT 71.7M
- INCR 76.7M
- IPO Year
- VLT N/A
- INCR N/A
- Fundamental
- Price
- VLT $10.60
- INCR $1.38
- Analyst Decision
- VLT
- INCR
- Analyst Count
- VLT 0
- INCR 0
- Target Price
- VLT N/A
- INCR N/A
- AVG Volume (30 Days)
- VLT 22.9K
- INCR 15.9K
- Earning Date
- VLT 01-01-0001
- INCR 04-08-2025
- Dividend Yield
- VLT 10.80%
- INCR N/A
- EPS Growth
- VLT N/A
- INCR N/A
- EPS
- VLT 0.64
- INCR N/A
- Revenue
- VLT N/A
- INCR $72,420,918.00
- Revenue This Year
- VLT N/A
- INCR N/A
- Revenue Next Year
- VLT N/A
- INCR $39.30
- P/E Ratio
- VLT $16.69
- INCR N/A
- Revenue Growth
- VLT N/A
- INCR N/A
- 52 Week Low
- VLT $9.29
- INCR $1.17
- 52 Week High
- VLT $10.93
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- VLT 29.00
- INCR 28.72
- Support Level
- VLT $10.58
- INCR $1.37
- Resistance Level
- VLT $10.76
- INCR $1.49
- Average True Range (ATR)
- VLT 0.09
- INCR 0.06
- MACD
- VLT -0.01
- INCR -0.02
- Stochastic Oscillator
- VLT 6.06
- INCR 3.98
About VLT Invesco High Income Trust II
Invesco High Income Trust II is a diversified, closed-end management investment company. Its investment objective is to provide high current income, while seeking to preserve shareholders' capital through investment in a professionally managed, diversified portfolio of high-income producing fixed-income securities.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.